Press Release
News
Press Release
News
Home News
Press Release
COMPANY NEWS
Ascentage Pharma Announces Promising Phase 1 Interim Results in Two Clinical Programs to Be Presented at 2018 ASCO Annual Meeting
Ascentage Pharma Announces Promising Phase 1 Interim Results in Two Clinical Programs to Be Presented at 2018 ASCO Annual Meeting

ROCKVILLE, Md. and HONG KONG, CHINA, May. 21, 2018 /PRNewswire-- Ascentage Pharma,a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies for cancers and other diseases, today announced that int…